株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

中枢神経系医薬品の世界市場:鎮痛薬・抗パーキンソン薬・麻酔薬・抗てんかん薬・その他

Central Nervous System Drugs Global Market Report 2019

発行 The Business Research Company 商品コード 531325
出版日 ページ情報 英文 300 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=111.21円で換算しております。
Back to Top
中枢神経系医薬品の世界市場:鎮痛薬・抗パーキンソン薬・麻酔薬・抗てんかん薬・その他 Central Nervous System Drugs Global Market Report 2019
出版日: 2019年01月01日 ページ情報: 英文 300 Pages
概要

当レポートでは、世界の中枢神経系医薬品の市場を調査し、市場の定義と概要、市場への各種影響因子の分析、薬剤区分・地域・国別の動向と市場規模の推移と予測、マクロ経済因子・ヘルスケア市場全体・各種産業指標との比較、競合環境、企業プロファイルなどをまとめています。

第1章 市場の特徴

第2章 市場規模・成長率

  • 市場成長:これまでの経緯
    • 成長推進因子
    • 成長抑制因子
  • 市場成長:予測
    • 成長推進因子
    • 成長抑制因子

第3章 PESTLE分析

第4章 顧客情報

第5章 中枢神経系医薬品市場の分析:区分別

  • 世界市場の実績:区分別
    • 鎮痛薬
    • 抗パーキンソン薬
    • 麻酔薬
    • 抗てんかん薬
    • その他
  • 世界市場の推移と予測:区分別
  • 市場動向・戦略

第6章 中枢神経系医薬品市場の分析:地域・国別分析

  • 世界市場の実績:地域別
  • 世界市場の推移と予測:地域別
  • 市場実績:国別
  • 市場の推移と予測:国別
  • 世界の医薬品市場の実績:区分・地域別
  • 世界の医薬品市場の実績:区分・国別

第7章 マクロ経済因子と市場の比較

  • 市場規模のGDPに占める割合
  • 一人当たりの平均支出額

第8章 マクロ経済因子と市場の比較:国別

  • 市場規模のGDPに占める割合:国別
  • 一人当たりの平均支出額:国別

第9章 産業指標と市場の比較

  • 世界の薬剤師数:国別
  • 市場収益 vs 薬剤師数:国別
  • 世界の医薬品会社数:国別
  • 市場収益 vs 医薬品会社数:国別
  • 世界のR&D/製品開発への平均支出額:国別
  • 市場収益 vs R&D/製品開発への平均支出額:国別
  • 世界のジェネリック&ブランド売上の割合:国別
  • 市場収益 vs ジェネリック&ブランド売上の割合:国別
  • パーキンソン病の有病者数:国別
  • 世界の精神科医数:国別
  • 市場収益 vs 精神科医数:国別
  • 世界の一般開業医の数:国別
  • 市場収益 vs 一般開業医数:国別

第10章 アジア太平洋市場

  • 市場概要
  • 市場の過去の推移
  • 市場予測
  • 市場実績:区分別
  • 国別分析
  • 中国
  • インド
  • 日本
  • オーストラリア

第11章 西欧市場

  • 市場概要
  • 市場の過去の推移
  • 市場予測
  • 市場実績:区分別
  • 国別分析
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン

第12章 東欧市場

  • 市場概要
  • 市場の過去の推移
  • 市場予測
  • 市場実績:区分別
  • 国別分析
  • ロシア

第13章 北米市場

  • 市場概要
  • 市場の過去の推移
  • 市場予測
  • 市場実績:区分別
  • 国別分析
  • 米国

第14章 南米市場

  • 市場概要
  • 市場の過去の推移
  • 市場予測
  • 市場実績:区分別
  • 国別分析
  • ブラジル

第15章 中東市場

  • 市場概要
  • 市場の過去の推移
  • 市場予測
  • 市場実績:区分別

第16章 アフリカ市場

  • 市場概要
  • 市場の過去の推移
  • 市場予測
  • 市場実績:区分別

第17章 競合環境

  • 企業プロファイル
  • Pfizer Inc.
  • Biogen Idec
  • Novartis Ag
  • 大塚製薬
  • Teva 医薬品

第18章 主要M&A:中枢神経系医薬品市場

第19章 市場背景:医薬品市場

第20章 医薬品産業のファイナンシャルマージン

第21章 付録

目次

Central Nervous System Drugs Market Global Report 2019 from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global central nervous system drugs market.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Description:

Where is the largest and fastest growing market for the central nervous system drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Central Nervous System Drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider pharmaceutical drugs market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.
  • The central nervous system drugs market section of the report gives context. It compares the central nervous system drugs market with other segments of the pharmaceutical drugs market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, central nervous system drugs indicators comparison.

Scope

Markets Covered: Nervous System Drugs, Analgesics, Anti-Parkinson drugs, Anesthetics, Anti-Epileptics, Other CNS drugs

Companies Mentioned: Biogen Inc, F. Hoffmann-La Roche Ltd, Johnson & Johnson, Pfizer Inc, Novartis AG

Metrics Covered: Parkinson Prevalence Rate, Number of Enterprises, Number of Employees

Countries: Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, Vietnam

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Time series: Five years historic and forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita, central nervous system drugs indicators comparison.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Report Structure

3. Central Nervous System Drugs Market Characteristics

  • 3.1. Market Definition
  • 3.2. Key Segmentations

4. Central Nervous System Drugs Market Product Analysis

  • 4.1. Leading Products/ Services
  • 4.2. Key Features and Differentiators
  • 4.3. Development Products

5. Central Nervous System Drugs Market Supply Chain

  • 5.1. Supply Chain
  • 5.2. Distribution
  • 5.3. End Customers

6. Central Nervous System Drugs Market Customer Information

  • 6.1. Customer Preferences
  • 6.2. End Use Market Size and Growth

7. Central Nervous System Drugs Market Trends And Strategies

8. Central Nervous System Drugs Market Size And Growth

  • 8.1. Market Size
  • 8.2. Historic Market Growth, Value ($ Billion)
    • 8.2.1. Drivers Of The Market
    • 8.2.2. Restraints On The Market
  • 8.3. Forecast Market Growth, Value ($ Billion)
    • 8.3.1. Drivers Of The Market
    • 8.3.2. Restraints On The Market

9. Central Nervous System Drugs Market Regional Analysis

  • 9.1. Global Central Nervous System Drugs Market, 2018, By Region, Value ($ Billion)
  • 9.2. Global Central Nervous System Drugs Market, 2014 - 2022, Historic And Forecast, By Region
  • 9.3. Global Central Nervous System Drugs Market, Growth And Market Share Comparison, By Region

10. Central Nervous System Drugs Market Segmentation

  • 10.1. Global Central Nervous System Drugs Market, Segmentation By Type, 2014 - 2022, Value ($ Billion)
    • 10.1.1. Nervous System Drugs
    • 10.1.2. Analgesics
    • 10.1.3. Anti-Parkinson drugs
    • 10.1.4. Anesthetics
    • 10.1.5. Anti-Epileptics
    • 10.1.6. Other CNS drugs

11. Central Nervous System Drugs Market Metrics

  • 11.1. Central Nervous System Drugs Market Size, Percentage Of GDP, 2014 - 2022, Global
  • 11.2. Per Capita Average Central Nervous System Drugs Market Expenditure, 2014 - 2022, Global

12. Asia-Pacific Central Nervous System Drugs Market

  • 12.1. Asia-Pacific Central Nervous System Drugs Market Overview
  • 12.2. Asia-Pacific, Central Nervous System Drugs Market, 2018, By Country, Value ($ Billion)
  • 12.3. Asia-Pacific, Central Nervous System Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • 12.4. Asia-Pacific, Central Nervous System Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • 12.5. Asia-Pacific, Central Nervous System Drugs Market Metrics
    • 12.5.1. Per Capita Average Central Nervous System Drugs Expenditure, 2014 - 2022, Asia-Pacific Countries
    • 12.5.2. Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2018, Asia-Pacific Countries
  • 12.6. Asia-Pacific Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • 12.7. Asia-Pacific Central Nervous System Drugs Market: Country Analysis
    • 12.7.1. China Central Nervous System Drugs Market
      • 12.7.1.1. China Central Nervous System Drugs Market Overview
      • 12.7.1.2. China Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
      • 12.7.1.3. China Central Nervous System Drugs Market, 2014 - 2022, Volume (Million Units)
      • 12.7.1.4. China Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
    • 12.7.2. Australia Central Nervous System Drugs Market
      • 12.7.2.1. Australia Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
      • 12.7.2.2. Australia Central Nervous System Drugs Market, 2014 - 2022, Volume (Million Units)
      • 12.7.2.3. Australia Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
    • 12.7.3. Hong Kong Central Nervous System Drugs Market
      • 12.7.3.1. Hong Kong Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
    • 12.7.4. India Central Nervous System Drugs Market
      • 12.7.4.1. India Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
      • 12.7.4.2. India Central Nervous System Drugs Market, 2014 - 2022, Volume (Million Units)
      • 12.7.4.3. India Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
    • 12.7.5. Indonesia Central Nervous System Drugs Market
      • 12.7.5.1. Indonesia Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
    • 12.7.6. Japan Central Nervous System Drugs Market
      • 12.7.6.1. Japan Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
      • 12.7.6.2. Japan Central Nervous System Drugs Market, 2014 - 2022, Volume (Million Units)
      • 12.7.6.3. Japan Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
    • 12.7.7. Malaysia Central Nervous System Drugs Market
      • 12.7.7.1. Malaysia Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
    • 12.7.8. New Zealand Central Nervous System Drugs Market
      • 12.7.8.1. New Zealand Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
    • 12.7.9. Philippines Central Nervous System Drugs Market
      • 12.7.9.1. Philippines Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
    • 12.7.10. Singapore Central Nervous System Drugs Market
      • 12.7.10.1. Singapore Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
    • 12.7.11. South Korea Central Nervous System Drugs Market
      • 12.7.11.1. South Korea Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
    • 12.7.12. Thailand Central Nervous System Drugs Market
      • 12.7.12.1. Thailand Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
    • 12.7.13. Vietnam Central Nervous System Drugs Market
      • 12.7.13.1. Vietnam Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)

13. Western Europe Central Nervous System Drugs Market

  • 13.1. Western Europe Central Nervous System Drugs Market Overview
  • 13.2. Western Europe, Central Nervous System Drugs Market, 2018, By Country, Value ($ Billion)
  • 13.3. Western Europe, Central Nervous System Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • 13.4. Western Europe, Central Nervous System Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • 13.5. Western Europe, Central Nervous System Drugs Market Metrics
    • 13.5.1. Per Capita Average Central Nervous System Drugs Expenditure, 2014 - 2022, Western Europe Countries
    • 13.5.2. Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2018, Western Europe Countries
  • 13.6. Western Europe Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • 13.7. Western Europe Central Nervous System Drugs Market: Country Analysis
    • 13.7.1. Austria Central Nervous System Drugs Market
      • 13.7.1.1. Austria Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
    • 13.7.2. Belgium Central Nervous System Drugs Market
      • 13.7.2.1. Belgium Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
    • 13.7.3. Denmark Central Nervous System Drugs Market
      • 13.7.3.1. Denmark Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
    • 13.7.4. Finland Central Nervous System Drugs Market
      • 13.7.4.1. Finland Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
    • 13.7.5. France Central Nervous System Drugs Market
      • 13.7.5.1. France Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
      • 13.7.5.2. France Central Nervous System Drugs Market, 2014 - 2022, Volume (Million Units)
      • 13.7.5.3. France Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
    • 13.7.6. Germany Central Nervous System Drugs Market
      • 13.7.6.1. Germany Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
      • 13.7.6.2. Germany Central Nervous System Drugs Market, 2014 - 2022, Volume (Million Units)
      • 13.7.6.3. Germany Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
    • 13.7.7. Ireland Central Nervous System Drugs Market
      • 13.7.7.1. Ireland Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
    • 13.7.8. Italy Central Nervous System Drugs Market
      • 13.7.8.1. Italy Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
      • 13.7.8.2. Italy Central Nervous System Drugs Market, 2014 - 2022, Volume (Million Units)
      • 13.7.8.3. Italy Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
    • 13.7.9. Netherlands Central Nervous System Drugs Market
      • 13.7.9.1. Netherlands Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
    • 13.7.10. Norway Central Nervous System Drugs Market
      • 13.7.10.1. Norway Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
    • 13.7.11. Portugal Central Nervous System Drugs Market
      • 13.7.11.1. Portugal Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
    • 13.7.12. Spain Central Nervous System Drugs Market
      • 13.7.12.1. Spain Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
      • 13.7.12.2. Spain Central Nervous System Drugs Market, 2014 - 2022, Volume (Million Units)
      • 13.7.12.3. Spain Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
    • 13.7.13. Sweden Central Nervous System Drugs Market
      • 13.7.13.1. Sweden Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
    • 13.7.14. Switzerland Central Nervous System Drugs Market
      • 13.7.14.1. Switzerland Central Nervous System Drugs Market2013 - 2022, Value ($ Billion)
    • 13.7.15. UK Central Nervous System Drugs Market
      • 13.7.15.1. UK Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
      • 13.7.15.2. UK Central Nervous System Drugs Market, 2014 - 2022, Volume (Million Units)
      • 13.7.15.3. UK Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)

14. Eastern Europe Central Nervous System Drugs Market

  • 14.1. Eastern Europe Central Nervous System Drugs Market Overview
  • 14.2. Eastern Europe, Central Nervous System Drugs Market, 2018, By Country, Value ($ Billion)
  • 14.3. Eastern Europe, Central Nervous System Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • 14.4. Eastern Europe, Central Nervous System Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • 14.5. Eastern Europe, Central Nervous System Drugs Market Metrics
    • 14.5.1. Per Capita Average Central Nervous System Drugs Expenditure, 2014 - 2022, Eastern Europe Countries
    • 14.5.2. Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2018, Eastern Europe Countries
  • 14.6. Eastern Europe Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • 14.7. Eastern Europe Central Nervous System Drugs Market: Country Analysis
    • 14.7.1. Czech Republic Central Nervous System Drugs Market,
      • 14.7.1.1. Czech Republic Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
    • 14.7.2. Poland Central Nervous System Drugs Market
      • 14.7.2.1. Poland Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
    • 14.7.3. Romania Central Nervous System Drugs Market
      • 14.7.3.1. Romania Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
    • 14.7.4. Russia Central Nervous System Drugs Market
      • 14.7.4.1. Russia Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
      • 14.7.4.2. Russia Central Nervous System Drugs Market, 2014 - 2022, Volume (Million Units)
      • 14.7.4.3. Russia Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)

15. North America Central Nervous System Drugs Market

  • 15.1. North America Central Nervous System Drugs Market Overview
  • 15.2. North America, Central Nervous System Drugs Market, 2018, By Country, Value ($ Billion)
  • 15.3. North America, Central Nervous System Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • 15.4. North America, Central Nervous System Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • 15.5. North America, Central Nervous System Drugs Market Metrics
    • 15.5.1. Per Capita Average Central Nervous System Drugs Expenditure, 2014 - 2022, North America Countries
    • 15.5.2. Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2018, North America Countries
  • 15.6. North America Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • 15.7. North America Central Nervous System Drugs Market: Country Analysis
    • 15.7.1. Canada Central Nervous System Drugs Market
      • 15.7.1.1. Canada Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
    • 15.7.2. Mexico Central Nervous System Drugs Market
      • 15.7.2.1. Mexico Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
    • 15.7.3. USA Central Nervous System Drugs Market
      • 15.7.3.1. USA Central Nervous System Drugs Market Overview
      • 15.7.3.2. USA Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
      • 15.7.3.3. USA Central Nervous System Drugs Market, 2014 - 2022, Volume (Million Units)
      • 15.7.3.4. USA Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)

16. South America Central Nervous System Drugs Market

  • 16.1. South America Central Nervous System Drugs Market Overview
  • 16.2. South America, Central Nervous System Drugs Market, 2018, By Country, Value ($ Billion)
  • 16.3. South America, Central Nervous System Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • 16.4. South America, Central Nervous System Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • 16.5. South America, Central Nervous System Drugs Market Metrics
    • 16.5.1. Per Capita Average Central Nervous System Drugs Expenditure, 2014 - 2022, South America Countries
    • 16.5.2. Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2018, South America Countries
  • 16.6. South America Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • 16.7. South America Central Nervous System Drugs Market: Country Analysis
    • 16.7.1. Argentina Central Nervous System Drugs Market
      • 16.7.1.1. Argentina Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
    • 16.7.2. Brazil Central Nervous System Drugs Market
      • 16.7.2.1. Brazil Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
      • 16.7.2.2. Brazil Central Nervous System Drugs Market, 2014 - 2022, Volume (Million Units)
      • 16.7.2.3. Brazil Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
    • 16.7.3. Chile Central Nervous System Drugs Market
      • 16.7.3.1. Chile Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
    • 16.7.4. Colombia Central Nervous System Drugs Market
      • 16.7.4.1. Colombia Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
    • 16.7.5. Peru Central Nervous System Drugs Market
      • 16.7.5.1. Peru Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
    • 16.7.6. Venezuela Central Nervous System Drugs Market
      • 16.7.6.1. Venezuela Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)

17. Middle East Central Nervous System Drugs Market

  • 17.1. Middle East Central Nervous System Drugs Market Overview
  • 17.2. Middle East, Central Nervous System Drugs Market, 2018, By Country, Value ($ Billion)
  • 17.3. Middle East, Central Nervous System Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • 17.4. Middle East, Central Nervous System Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • 17.5. Middle East, Central Nervous System Drugs Market Metrics
    • 17.5.1. Per Capita Average Central Nervous System Drugs Expenditure, 2014 - 2022, Middle East Countries
    • 17.5.2. Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2018, Middle East Countries
  • 17.6. Middle East Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • 17.7. Middle East Central Nervous System Drugs Market: Country Analysis
    • 17.7.1. Saudi Arabia Central Nervous System Drugs Market
      • 17.7.1.1. Saudi Arabia Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
    • 17.7.2. Israel Central Nervous System Drugs Market
      • 17.7.2.1. Israel Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
    • 17.7.3. Turkey Central Nervous System Drugs Market
      • 17.7.3.1. Turkey Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
    • 17.7.4. UAE Central Nervous System Drugs Market
      • 17.7.4.1. UAE Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)

18. Africa Central Nervous System Drugs Market

  • 18.1. Africa Central Nervous System Drugs Market Overview
  • 18.2. Africa, Central Nervous System Drugs Market, 2018, By Country, Value ($ Billion)
  • 18.3. Africa, Central Nervous System Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • 18.4. Africa, Central Nervous System Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • 18.5. Africa, Central Nervous System Drugs Market Metrics
    • 18.5.1. Per Capita Average Central Nervous System Drugs Expenditure, 2014 - 2022, Africa Countries
    • 18.5.2. Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2018, Africa Countries
  • 18.6. Africa Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • 18.7. Africa Central Nervous System Drugs Market: Country Analysis
    • 18.7.1. Egypt Central Nervous System Drugs Market
      • 18.7.1.1. Egypt Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
    • 18.7.2. Nigeria Central Nervous System Drugs Market
      • 18.7.2.1. Nigeria Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
    • 18.7.3. South Africa Central Nervous System Drugs Market
      • 18.7.3.1. South Africa Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)

19. Central Nervous System Drugs Market Competitive Landscape

  • 19.1. Competitive Market Overview
  • 19.2. Market Shares
  • 19.3. Company Profiles
    • 19.3.1. Biogen Inc
      • 19.3.1.1. Company Overview
      • 19.3.1.2. Company Central Nervous System Drugs Market Structure And Strategy
      • 19.3.1.3. Company Central Nervous System Drugs Market Products And Services
      • 19.3.1.4. Financial Performance
    • 19.3.2. F. Hoffmann-La Roche Ltd
      • 19.3.2.1. Company Overview
      • 19.3.2.2. Company Central Nervous System Drugs Market Structure And Strategy
      • 19.3.2.3. Company Central Nervous System Drugs Market Products And Services
      • 19.3.2.4. Financial Performance
    • 19.3.3. Johnson & Johnson
      • 19.3.3.1. Company Overview
      • 19.3.3.2. Company Central Nervous System Drugs Market Structure And Strategy
      • 19.3.3.3. Company Central Nervous System Drugs Market Products And Services
      • 19.3.3.4. Financial Performance
    • 19.3.4. Pfizer Inc
      • 19.3.4.1. Company Overview
      • 19.3.4.2. Company Central Nervous System Drugs Market Structure And Strategy
      • 19.3.4.3. Company Central Nervous System Drugs Market Products And Services
      • 19.3.4.4. Financial Performance
    • 19.3.5. Novartis AG
      • 19.3.5.1. Company Overview
      • 19.3.5.2. Company Central Nervous System Drugs Market Structure And Strategy
      • 19.3.5.3. Company Central Nervous System Drugs Market Products And Services
      • 19.3.5.4. Financial Performance

20. Key Mergers And Acquisitions In The Central Nervous System Drugs Market

21. Market Background: Pharmaceutical Drugs Market

  • 21.1. Pharmaceutical Drugs Market Characteristics
  • 21.2. Pharmaceutical Drugs Market Historic and Forecast, 2014 - 2022 Growth, by segment, Value ($ Billion), Global
  • 21.3. Global Pharmaceutical Drugs Market, 2018, By Region, Value ($ Billion)
  • 21.4. Global Pharmaceutical Drugs Market, 2014 - 2022, Historic And Forecast, By Region
  • 21.5. Global Pharmaceutical Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)

22. Recommendations

  • 22.1. Global Central Nervous System Drugs Market In 2022- Growth Countries
  • 22.2. Global Central Nervous System Drugs Market In 2022- Growth Segments
  • 22.3. Global Central Nervous System Drugs Market In 2022- Growth Strategies

23. Appendix

  • 23.1. NAICS Definitions Of Industry Covered In This Report
  • 23.2. Abbreviations
  • 23.3. Currencies
  • 23.4. Research Inquiries
  • 23.5. The Business Research Company

24. Copyright And Disclaimer

Back to Top